03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Betaval Ointment* : | |
Type | Medicine Non Marketed |
Originator | Betnovate Ointment |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Hikma Pharmaceuticals |
Responsible Party | Arab Pharmaceutical Manufacturer Co Ltd |
Origin | Jordan |
Manufacturer | The Arab Pharmaceutical Manufacturing Co Ltd |
Manufacturing Type | G |
Origin | Jordan |
ATC | D07AC01 |
Betaval Ointment* :
Betaval Ointment* :
Betaval Ointment* :
Betaval Ointment* :
Betaval Ointment* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Betaval Ointment* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Allergic contact dermatitis | Very rare |
Alopecia | Very rare |
Application site irritation | Very rare |
Application site pain | Very rare |
Blood cortisol decreased | Very rare |
Cataract | Very rare |
Cushing-like symptoms | Very rare |
Dermatitis | Very rare |
Dry skin | Very rare |
Erythema | Very rare |
Glaucoma | Very rare |
Glucosuria (Glycosuria) | Very rare |
Growth retardation | Very rare |
Hair breakage | Very rare |
Hair discoloration | Very rare |
Hyperglycaemia | Very rare |
Hypersensitivity reactions | Very rare |
Hypertension | Very rare |
Hypertrichosis | Very rare |
Hypothalamic pituitary adrenal axis suppression | Very rare |
Obesity | Very rare |
Opportunistic infections | Very rare |
Osteoporosis | Very rare |
Pain | Common |
Pigmentation disorder | Very rare |
Pruritus | Common |
Pustular psoriasis | Very rare |
Skin atrophy | Very rare |
Skin burning sensation | Common |
Skin Eruption | Very rare |
Skin thinning | Very rare |
Stretch marks (Striae) | Very rare |
Telangiectasia | Very rare |
Truncal obesity | Very rare |
Urticaria | Very rare |
Weight increased (weight gain) | Very rare |
Betaval Ointment* :
NB : Products With Same Indication |
Different Units By MoH Code
Betaval Ointment* MoH 1378 :
Form | Cutaneous ointment |
Packaging | Tube |
Package Size | 15g |
Strength | 0.1% |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 27693 |
Submission date | 01/01/1994 |
Registration Year | 1994 |
Archived Date | 2014 |
Price Comparison
● Country: | KSA | |
● Package Size: | 15g | |
● Public Price: | 2.7 SAR | ( 63,828.00 LBP ) |
● Pack size unit used: | 15 | |
● Cost/Unit: | 0,18 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 30g | |
● Public Price: | 7 QAR | ( 171,906.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,2333 QAR | ( 0.00 LBP ) |
● Pharmacy Price: | 5.544648797838 QAR | ( 136165.48517731 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 15g Tube | |
● Public Price: | 2.5 AED | ( 60,402.50 LBP ) |
● Pack size unit used: | 15 | |
● Cost/Unit: | 0,1667 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 2.24 AED | ( 54120.64 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 15g | |
● Public Price: | 2.5 AED | ( 60,402.50 LBP ) |
● Pack size unit used: | 15 | |
● Cost/Unit: | 0,1667 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 2.24 AED | ( 54120.64 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 15g | |
● Public Price: | 0.84 JOD | ( 105,185.64 LBP ) |
● Pack size unit used: | 15 | |
● Cost/Unit: | 0,056 JOD | ( 0.00 LBP ) |
● Pharmacy Price: | 0.64 JOD | ( 80141.44 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File